Xcell Therapeutics, Inc.
KOE: 373110.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Uri Lee
- Employees
- 60
- Headquarters
- Guro-gu, South Korea
- IPO year
- 2024
- Market cap
- ₩19.2B
- Website
- http://www.xcelltherapeutics.com
Loading 373110…
Loading profile data…Frequently asked questions about 373110
What does Xcell Therapeutics, Inc. (373110.KQ) do?
Xcell Therapeutics, Inc. creates ethical technologies and tools for research and development in the life sciences. The company was founded in 2015 and is headquartered in Guro-gu, South Korea.
Where does 373110.KQ trade?
Xcell Therapeutics, Inc. (373110.KQ) trades on the KOSDAQ.
What sector is 373110.KQ in?
Xcell Therapeutics, Inc. (373110.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Xcell Therapeutics, Inc.?
Uri Lee is the chief executive officer of Xcell Therapeutics, Inc. (373110.KQ).
Where is Xcell Therapeutics, Inc. headquartered?
Xcell Therapeutics, Inc. is headquartered in South Korea.
Does 373110.KQ pay a dividend?
Xcell Therapeutics, Inc. (373110.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 373110.KQ go public?
Xcell Therapeutics, Inc. (373110.KQ) completed its initial public offering in 2024.